NLRP3 and amyotrophic lateral sclerosis: Therefore, in addition to diminishing the activity of the NLRP3 inflammasome induced by GA50, IFT may also have neuroprotective activities in regulating cellular anti-oxidation, anti-inflammation, and clearing amyloid in C9-ALS patients.